CPHI Milan 2026
10/2026 – 10/2026
Über das Unternehmen
- Firmenname (rechtlich): Advenza Global Limited
- Registrierungsland: India
- Adresse: Unit No. 424, 4th Floor, Lodha Supremus II, Rd Number 22, Wagle Industrial Estate, Thane
- Anzahl der Mitarbeiter: 100 - 249
- Gründungsjahr: 2005
Beschreibung:
A leading provider of probiotic and enzyme-based formulations in India, dedicated to improving human and animal health through scientifically backed products. With more than 65 years of expertise, Advenza delivers innovative, high-quality finished formulations across dosage forms including tablets, capsules, drops, stick packs and ampoules, offering a one-stop shop for clients.
Geschäftsaktivitäten
Vertrags- & Outsourcing-Dienstleistungen
Hersteller
Fertigarzneiformen
Hersteller
Naturextrakte & Pflanzliche Rohstoffe
Hersteller
ATC-Klassifikation (Anatomisch-Therapeutisch-Chemisch)
Hersteller
Absatzmärkte
- East Asia: China, Democratic People's Republic of Korea, Mongolia, Republic of Korea, Japan, Taiwan
- South Asia: Bangladesh, Bhutan, India, Maldives, Nepal, Pakistan, Sri Lanka, Afghanistan, Iran
- Mainland Southeast Asia: Cambodia, Lao People's Democratic Republic, Myanmar, Thailand, Viet Nam, Brunei Darussalam, Indonesia, Malaysia, Philippines, Timor-Leste, Singapore
- Northern Europe: Denmark, Estonia, Finland, Iceland
Hauptprodukte/-dienstleistungen
- Pharmazeutische Wirkstoffe (API): Bacillus Clausii Suspension, Lacticaseibacellus rhamnosus GG Stick Pack
- Vertrags- & Outsourcing-Dienstleistungen: Vegan Formulation For Pain Management
- Fertigarzneiformen: Lactase Drops and Tablets, Multi-enzyme Digestive Tablets
- Biologische & Fermentationsrohstoffe: Multi-enzyme Digestive Tablets, Probiotic formulations, Enzyme formulations, Enzyme + probiotic blends, Probiotics with botanical extracts
- Original-Wirkstoffe: Systemic Enzymes with Probiotics, Digestive Health Supplement, Customized Blends Enzymes & Probiotics (Poultry), Bacillus coagulans, Bacillus clausii, Bacillus amyloliquefaciens, Bacillus licheniformis, Bacillus megaterium, Bacillus subtilis, Bifidobacterium animalis subsp. lactis, Bifidobacterium breve, Bifidobacterium longum, Lacticaseibacillus casei, Lacticaseibacillus paracasei, Lactobacillus plantarum, Lactobacillus rhamnosus GG ( ATCC 53103), Limosilactobacillus reuteri
- Tierarzneimittel & Futtermittelzusatzstoffe: Animal health formulations
Unsere Produkte & Dienstleistungen
Sell · Active Pharmaceutical Ingredients (APIs)
Proofs
Bewertungen
(0)
(0)
(0)
(0)
(0)
Kommentare
Filter:
Sortieren nach:
Keine Kommentare verfügbar.
Bewertung & Kommentar hinterlassen